Genetic testing in the contemporary diagnosis of cardiomyopathy

Amy Curry Sturm1

  • 1Division of Human Genetics, Internal Medicine, Wexner Medical Center at The Ohio State University, 2001 Polaris Parkway, Columbus, OH 43240, USA. amy.sturm@osumc.edu

Insights

Heritable cardiomyopathies are common genetic heart conditions. Genetic testing and counseling are crucial for diagnosis, identifying at-risk relatives, and guiding management for these heart diseases.

Area of Science:

  • Cardiology
  • Genetics
  • Medical Diagnostics

Background:

  • Heritable cardiomyopathies are prevalent genetic disorders.
  • These conditions significantly increase the risk of heart failure and sudden cardiac death.
  • Current guidelines recommend family history, genetic testing, and counseling for affected individuals.

Purpose of the Study:

  • To highlight the importance of genetic testing in managing heritable cardiomyopathies.
  • To emphasize the role of genetic counseling in patient care.
  • To discuss the benefits and limitations of genetic testing.

Main Methods:

  • Review of current practice guidelines and consensus statements.
  • Discussion of advancements in DNA sequencing technologies and genetic testing panels.
  • Emphasis on the integration of genetic testing and counseling in clinical practice.

Main Results:

  • Genetic testing panels for cardiomyopathies are now widely available due to technological advances and cost reductions.
  • Genetic testing aids in identifying the specific cause of cardiomyopathies.
  • Genetic testing is instrumental in determining which family members are at risk.

Conclusions:

  • Genetic testing is a valuable tool for diagnosing and managing heritable cardiomyopathies.
  • Genetic counseling, both pre- and post-test, is essential for informed decision-making.
  • Comprehensive genetic evaluation benefits patients and their families by clarifying risk and guiding care.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...